Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G/A Sanofi Filed by: Amundi

April 10, 2026 9:58 AM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Amundi does not have voting rights on 27,407,379 shares which are held through a FCPE (Fonds Commun de Placement d'Enterprise, an investment vehicle established under French law), solely dedicated to Sanofi group's employees shareholding. Employees of Sanofi are granted the right to participate in stock purchase plans in which the shares acquired are exclusively held in this FCPE, created at the request of Sanofi. The voting rights associated to these shares are exercised by the supervisory Board of the FCPE, where representatives of the employees have the majority (if any remaining seats of the supervisory board are designated by Sanofi), and not by Amundi.


SCHEDULE 13G




Comment for Type of Reporting Person: Amundi does not have voting rights on 27,407,379 shares which are held through a FCPE (Fonds Commun de Placement d'Enterprise, an investment vehicle established under French law), solely dedicated to Sanofi group's employees shareholding. Employees of Sanofi are granted the right to participate in stock purchase plans in which the shares acquired are exclusively held in this FCPE, created at the request of Sanofi. The voting rights associated to these shares are exercised by the supervisory Board of the FCPE, where representatives of the employees have the majority (if any remaining seats of the supervisory board are designated by Sanofi), and not by Amundi.


SCHEDULE 13G



AMUNDI
Signature:John M. Malone
Name/Title:John M. Malone | Chief Compliance Officer | Power of Attorney
Date:04/10/2026
AMUNDI ASSET MANAGEMENT
Signature:John M. Malone
Name/Title:John M. Malone | Chief Compliance Officer | Power of Attorney
Date:04/10/2026

Categories

SEC Filings